Transcat, Inc. (TRNS)
| Market Cap | 874.37M +76.8% |
| Revenue (ttm) | 363.22M +20.0% |
| Net Income | 4.59M -59.6% |
| EPS | 0.49 -59.7% |
| Shares Out | 9.40M |
| PE Ratio | 189.48 |
| Forward PE | 89.14 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 139,767 |
| Open | 95.80 |
| Previous Close | 97.53 |
| Day's Range | 92.42 - 98.36 |
| 52-Week Range | 50.23 - 112.44 |
| Beta | 0.64 |
| Analysts | Strong Buy |
| Price Target | 110.80 (+19.18%) |
| Earnings Date | Nov 3, 2026 |
About TRNS
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. The company operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customersâ assets; and Compliance, Control, a... [Read more]
Financial Performance
In fiscal year 2026, Transcat's revenue was $331.88 million, an increase of 19.20% compared to the previous year's $278.42 million. Earnings were $5.38 million, a decrease of -62.96%.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for TRNS stock is "Strong Buy." The 12-month stock price target is $110.8, which is an increase of 19.18% from the latest price.
News
Transcat price target raised to $119 from $113 at Craig-Hallum
Craig-Hallum raised the firmâs price target on Transcat (TRNS) to $119 from $113 and keeps a Buy rating on the shares following one of the best quarterly prints in someâŠ
Transcat price target raised to $100 from $95 at Northland
Northland analyst Ted Jackson raised the firmâs price target on Transcat (TRNS) to $100 from $95 and keeps an Outperform rating on the shares.
Transcat upgraded to Outperform from Perform at Oppenheimer
Oppenheimer upgraded Transcat (TRNS) to Outperform from Perform with a $115 price target The firm says its prior caution centered on whether stronger organic growth could translate into sustained marg...
Transcat Earnings Call Transcript: Q2 2027
Q2 FY27 revenue rose 18%, with service organic growth accelerating to 16% and adjusted EBITDA margin expanding 70 bps. The FY27 service organic growth outlook was raised to low double digits, with H2 service and distribution margin expansion expected.
Transcat Earnings release: Q2 2027
Transcat released its Q2 2027 earnings on November 3, 2026, summarizing the period's financial results.
Transcat Quarterly report: Q2 2027
Transcat has published its Q2 2027 quarterly earnings report on November 3, 2026.
Transcat Slides: Q2 2027
Transcat has posted slides in relation to its Q2 2027 quarterly earnings report, which was published on November 3, 2026.
Transcat reports Q2 adjusted EPS 64c, consensus 45c
Reports Q2 revenue $97.1M, consensus $92.46M. âOur fiscal second quarter results demonstrate strong execution across each pillar of our core strategy: driving strong Service organic revenue growth, ex...
Transcat Reports Strong Fiscal Second Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Significant Service Gross Margin Expansion
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat Reports Strong Fiscal Second Quarter 2027 Financial Results with Double-Digit Service Organic Revenue Growth, Service Gross Margin Expansion.
Transcat to Attend Upcoming Investor Conferences in November
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat to Attend Upcoming Investor Conferences in November.
Transcat initiated with an Outperform at CJS Securities
CJS Securities initiated coverage of Transcat (TRNS) with an Outperform rating and $115 price target
Transcat upgraded to Outperform from Market Perform at Northland
Northland upgraded Transcat (TRNS) to Outperform from Market Perform with an unchanged price target of $95.
Transcat upgraded to Outperform at Northland on valuation
As previously reported, Northland upgraded Transcat (TRNS) to Outperform from Market Perform with an unchanged price target of $95 ahead of the company reporting Q2 results on Tuesday, November 17.
Transcat to Host Second Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, November 3, 2026 at 4:30 p.m. Eastern Time
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat to Host Second Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, November 3, 2026 at 4:30 p.m. Eastern Time.
Transcat Transcript: AGM 2026
The virtual annual meeting covered director elections, executive compensation, and auditor ratification, with all proposals passing by the required vote. Shareholders participated remotely, and final results will be filed with the SEC.
Transcat acquires Southeastern Biomedical Associates for $12.8M
Transcat (TRNS) acquired privately-held Southeastern Biomedical Associates Incorporated. The $12.8M purchase price was paid in cash and is subject to certain customary adjustments and holdback provisi...
Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical.
Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September.
Transcat management to meet with Northland
Investor Day and Calibration Lab Tour to be held in Cherry Hill, NJ on August 26 hosted by Northland.
Transcat downgraded to Market Perform from Outperform at Northland
Northland analyst Ted Jackson downgraded Transcat (TRNS) to Market Perform from Outperform with an unchanged price target of $95. Transcat reported âexceptionally strongâ fiscal Q1 results and the fir...
Transcat Earnings Call Transcript: Q1 2027
Q1 2027 saw 22% revenue growth, led by a 27% increase in service revenue and margin expansion, with strong demand in regulated markets and successful M&A integration. Management expects high single-digit organic service growth and continued margin gains for the year.
Transcat Earnings release: Q1 2027
Transcat released its Q1 2027 earnings on August 4, 2026, summarizing the period's financial results.
Transcat Quarterly report: Q1 2027
Transcat has published its Q1 2027 quarterly earnings report on August 4, 2026.
Transcat Slides: Q1 2027
Transcat has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 4, 2026.
Transcat reports Q1 adjusted EPS 51c, consensus 38c
Reports Q1 revenue $92.9M, consensus $86.55M. âPrior to discussing our strong financial performance, I want to share my observations and take aways after my first full quarter as CEO ofâŠ